Provider profile
ICON.
Clinical biometrics
ICON is a large CRO that documents biostatistics and statistical programming for Phase 1–4 studies, including SAPs, CDISC SDTM/ADaM, ISS/ISE, eSubmission packages, DMC support, adaptive design, SAS programming and pharmacometrics, plus clinical data management with EDC builds and real-world evidence analytics, offered as full-service, standalone or FSP. Its corporate headquarters is in Dublin, Ireland.
- Website
- iconplc.com (opens in a new tab)
- Sources reviewed
- November 3, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Adaptive and Bayesian design3
- Biostatistics1
- CDISC data standards1
- Clinical data management2
- Data monitoring committee support1
- EDC and database build2
- Integrated analyses (ISS/ISE)1
- PK analysis and pharmacometrics4
- Real-world evidence analytics1
- Statistical analysis plans1
- Statistical programming1
- Submission data packages1
Development experience
Development experience
Development stage
- Commercial1Stated as Phase 4 for biostatistics and statistical programming services
- Phase 11Stated for biostatistics and statistical programming services (Phase 1–4)
- Phase 21Stated for biostatistics and statistical programming services (Phase 1–4)
- Phase 31Stated for biostatistics and statistical programming services (Phase 1–4)
Locations
Locations
- Dublin, Ireland · Headquarters5
Quality and regulatory
Quality and regulatory
No quality framework or accreditation is established from reviewed sources. Ask for current certificates and recent inspection history.
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Named statistician and programming lead for your study, and their recent experience in your indication
- Current capacity and realistic start date for database build and SAP authoring
- Which CDISC standard versions and FDA Data Standards Catalog requirements they will deliver against
- EDC system(s) supported and who holds the licence
- Assumptions behind the budget: number of TLFs, interim analyses, DMC meetings and data transfers
- How change orders are triggered and priced
Not established from reviewed sources: therapeutic experience, quality frameworks (vendor-reported).
Evidence and sources
Evidence and sources
- 1Biostatistics | Clinical & Scientific Operations | ICON plc (opens in a new tab)ICON · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Clinical Data Management | ICON plc (opens in a new tab)ICON · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Adaptive clinical trial design software & consulting | ICON plc (opens in a new tab)ICON · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Pharmacokinetics | Early Phase | ICON plc (opens in a new tab)ICON · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5ICON plc | Global Office Locator (opens in a new tab)ICON · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.